We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Virtual Reality Hypnosis for Chronic Pain Reduction (VRHChP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01099657
Recruitment Status : Completed
First Posted : April 7, 2010
Last Update Posted : May 12, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
We would like to determine how well hypnosis works when induced through virtual reality medium for patients who have suffered a major burn injury in the past two years and suffer from chronic pain. These patients are coming back to the outpatient burn and plastic clinic at Harborview Medical Center for routine follow-up. We think that patients will find VR-Hypnosis interesting, and it will help them relax and feel less pain.

Condition or disease Intervention/treatment
Burns Behavioral: Virtual Reality Hypnosis for chronic pain Behavioral: Virtual Reality Distraction for Chronic Pain

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
Official Title: Virtual Reality Hypnosis for Chronic Pain Reduction
Study Start Date : June 2007
Primary Completion Date : May 2012
Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Virtual Reality Hypnosis
Virtual Reality Hypnosis for chronic pain
Behavioral: Virtual Reality Hypnosis for chronic pain
At the time of their clinic visit,the subject will answer pain and anxiety questionnaires before experiencing Virtual Reality Hypnosis. After VRH, the will again answer Pain and anxiety questionnaires.
Experimental: Virtual Reality Distraction
Virtual Reality Distraction for Chronic Pain
Behavioral: Virtual Reality Distraction for Chronic Pain
At the time of their clinic visit,the subject will answer pain and anxiety questionnaires before experiencing Virtual Reality Distraction. After VRD, the will again answer Pain and anxiety questionnaires.


Outcome Measures

Primary Outcome Measures :
  1. Pain and anxiety [ Time Frame: pre and post VR and then up to one month ]
    The subjects will answer questions regarding pain and anxiety at the time of their clinic visit, before and after experiencing virtual reality. Then the subject will be followed for up to one month.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   13 Years to 75 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 13 - 75 years
  • Able to complete subjective evaluations of pain
  • English-speaking
  • Able to communicate orally

Exclusion Criteria:

  • Age less than 13 years or greater than 75 years
  • Incapable of indicating subjective evaluation of pain
  • Non-English-speaking (Virtual Reality Hypnosis only available in English)
  • Demonstrating delirium, psychosis, or Organic Brain Disorder
  • Unable to communicate verbally
  • Significant developmental disability
  • Extreme susceptibility to motion sickness
  • Significant head/or neck injury
  • Pregnant women
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01099657


Locations
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 98104
Sponsors and Collaborators
University of Washington
National Institute of General Medical Sciences (NIGMS)
More Information

Responsible Party: Shelley A. Wiechman, Associate Professor, Rehabilitative Medicine, University of Washington
ClinicalTrials.gov Identifier: NCT01099657     History of Changes
Other Study ID Numbers: 31498
First Posted: April 7, 2010    Key Record Dates
Last Update Posted: May 12, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Chronic Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms